Geriatric Impairments and Low Muscle Mass Are Associated with Treatment Discontinuation and Overall Survival in Newly Diagnosed Non-Transplant Eligible Multiple Myeloma Patients (nte-NDMM) Treated with Dose-Adjusted Melphalan-Prednisone-Bortezomib (MPV) — Results of the Dutch HOVON 123 Study
暂无分享,去创建一个
K. Nasserinejad | P. Sonneveld | B. Lissenberg-Witte | H. Verheul | C. Eeltink | M. Minnema | M. Levin | S. Klein | P. Ypma | S. Zweegman | N. V. D. van de Donk | B. Tanis | Charlotte L B M Korst | W. Deenik | M. Westerman | C. Stege | N. V. D. Donk | Amanda C. Dijk | E. D. Waal | C. L. Korst | E. G. Waal | A. C. Dijk